ECSP17003149A - SUBSTITUTE DIHYDROISOQUINOLINONE COMPOUNDS - Google Patents

SUBSTITUTE DIHYDROISOQUINOLINONE COMPOUNDS

Info

Publication number
ECSP17003149A
ECSP17003149A ECIEPI20173149A ECPI201703149A ECSP17003149A EC SP17003149 A ECSP17003149 A EC SP17003149A EC IEPI20173149 A ECIEPI20173149 A EC IEPI20173149A EC PI201703149 A ECPI201703149 A EC PI201703149A EC SP17003149 A ECSP17003149 A EC SP17003149A
Authority
EC
Ecuador
Prior art keywords
compounds
substitute
salts
present
dihydroisoquinolinone
Prior art date
Application number
ECIEPI20173149A
Other languages
Spanish (es)
Inventor
Daniel Tyler Richter
Pei-Pei Kung
Martin James Wythes
Michael Raymond Collins
Robert Steven Kania
Robert Arnold Kumpf
Scott Channing Sutton
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP17003149A publication Critical patent/ECSP17003149A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de la Fórmula general (I) ((se agrega el gráfico de la fórmula descrita, en archivo adjunto)) en donde R1, R2, R3, R4, L, X y Z son como se definen en la presente, y las sales de estos aceptables desde el punto de vista farmacéutico, a composiciones farmacéuticas que comprenden tales compuestos y sales, y a métodos para usar tales compuestos, sales y composiciones para el tratamiento del crecimiento anormal de células, que incluye cáncer.The present invention refers to compounds of the general Formula (I) ((the graph of the described formula is added, in attached file)) where R1, R2, R3, R4, L, X and Z are as defined in the present, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.

ECIEPI20173149A 2014-06-17 2017-01-17 SUBSTITUTE DIHYDROISOQUINOLINONE COMPOUNDS ECSP17003149A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462013410P 2014-06-17 2014-06-17

Publications (1)

Publication Number Publication Date
ECSP17003149A true ECSP17003149A (en) 2017-09-29

Family

ID=58699775

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI20173149A ECSP17003149A (en) 2014-06-17 2017-01-17 SUBSTITUTE DIHYDROISOQUINOLINONE COMPOUNDS

Country Status (2)

Country Link
AR (1) AR100843A1 (en)
EC (1) ECSP17003149A (en)

Also Published As

Publication number Publication date
AR100843A1 (en) 2016-11-02

Similar Documents

Publication Publication Date Title
UY36170A (en) DIHYDROISOQUINOLINONA SUBSTITUTED COMPOUNDS
MX2016014547A (en) Compounds for treating spinal muscular atrophy.
UY38471A (en) AZALACTAM COMPOUNDS AS INHIBITORS OF HPK1
MX2016013689A (en) 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS.
MX2017007044A (en) NEW COMPOUNDS OF 5-AMINO-6H-TIAZOLO [4,5-D] PIRIMIDIN-2,7-DIONA 3-SUBSTITUTED FOR THE TREATMENT AND PROFILAXIS OF VIRAL INFECTIONS.
CU24411B1 (en) COMPOSITE DERIVED FROM BENZAMIDE REPLACED WITH 1,3-TIAZOL-2-ILO USEFUL FOR THE TREATMENT OF NEUROGENIC DISORDERS
CU20150062A7 (en) LACTAMAS N- (REPLACED HETEROARILE) USEFUL FUSIONATES IN THE TREATMENT OF ABNORMAL CELL GROWTH
MX2021005052A (en) Oxysterols and methods of use thereof.
MX2018000282A (en) Oxysterols and methods of use thereof.
MX2019002129A (en) NEW 7-SUBSTITUTED AND DERIVATIVE SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRAL INFECTION.
UY36702A (en) PIRIDINES REPLACED AND METHODS OF USE
CU20170085A7 (en) IMIDAZOLIDINDIONA DERIVATIVES FOR THE TREATMENT OF OSTEOARTRITIS
CO2019001181A2 (en) Heteroarylcarboxamide compounds as ripk2 inhibitors
GT201600091A (en) DERIVATIVES OF PURINA 2, 6-SUBSTITUTES AND ITS USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
UY35551A (en) HETEROARILE DERIVATIVES AS INHIBITORS OF ALDOSTERONA SINTASA
CU20170007A7 (en) IMIDAZOPIRIDAZINE COMPOUNDS
UY36228A (en) HETEROARILO DERIVATIVES AS INHIBITORS OF ALDOSTERONE SINTASA (CYP11B2) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX2017003788A (en) DERIVATIVES OF NUCLEOSIDS REPLACED WITH 4´-VINYL AS INHIBITORS OF THE REPLICATION OF THE RNA OF THE RESPIRATORY RESPIRATORY VIRUS.
PY1515461A (en) Dihydropyrrolopyrimidine Derivatives
DOP2016000293A (en) DERIVATIVES OF DIHETEROCICLO LINKED TO CYCLALKYL
UY35785A (en) PIPERAZINE DERIVATIVES REPLACED AS MODULATORS OF THE GLICINE-1 CONVEYOR (GLYT1)
NI201500172A (en) PHARMACEUTICAL COMPOSITIONS
ECSP17003149A (en) SUBSTITUTE DIHYDROISOQUINOLINONE COMPOUNDS
DOP2016000326A (en) DIHYDROISOQUINOLINONA SUBSTITUTED COMPOUNDS
CU20140033A7 (en) PIRROLOPIRIMIDINE AND PURINE DERIVATIVES